infliximab.n.02

'infliximab.n.02'

[infliximab.n.02] as in: an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis